Skip to main content
Caplight Logo









Oisín Biotechnologies

Oisín Biotechnologies

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.oisinbio.com/

Last Round

Grant

Dec 18, 2024

Total Funding Raised

$9.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Oisín Biotechnologies is a biotechnology company that develops genetic medicines to address age-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

senolytic therapysenescent cell clearancelongevity biotechnologygene therapyage-related diseasesdrug delivery platformanti-aging therapyproteo-lipid vehiclePLVDNA-based therapypreclinical biotechnologysuicide gene therapygenetic medicinesdrug licensingp16 biomarkerprogrammed cell death

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oisín Biotechnologies Comparables

Compare Oisín Biotechnologies with similar companies based on industry and business-model similarity.

Oisín Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Deciduous Therapeutics
82%
Rubedo Life Sciences
81%
Numeric Biotech
78%

Oisín Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 18, 2024
Series AJul 24, 2024
SeedMay 27, 2021
Pre SeedFeb 26, 2020
SeedMar 22, 2017

Key People

Founding team and executive leadership

Eric Garcia

Chief Operating Officer

Executive Team

Oisín Biotechnologies Investors

Notable investors and investment history

Oisín Biotechnologies investors
InvestorRounds
Kizoo Technology CapitalPre Seed
AbbVie VenturesSeries A
AltheaSeed
M-Fund VCPre Seed
SENS Research FoundationPre Seed, Seed
Methuselah FoundationGrant, Pre Seed, Seed
Advani Family OfficePre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 39% MoM, reaching 2.2K.

  • Jan 21, 2026

    Monthly visitors increased 137% MoM.

Oisín Biotechnologies Filings

Explore SEC and related filing metadata, where available.

Oisín Biotechnologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Oisín Biotechnologies's valuation, stock price, and market status.

Is Oisín Biotechnologies a public or private company?

Oisín Biotechnologies is a private company.

What is the current stock price of Oisín Biotechnologies?

Oisín Biotechnologies is a private company with no public stock price. No recent secondary market data is available.

How much is Oisín Biotechnologies worth (valuation)?

Valuation information for Oisín Biotechnologies is not publicly available.

Can I buy Oisín Biotechnologies stock?

Oisín Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Oisín Biotechnologies's last funding round?

Oisín Biotechnologies's most recent funding round was Grant on December 18, 2024.

Who are the main investors in Oisín Biotechnologies?

Key investors in Oisín Biotechnologies include AbbVie Ventures, Althea.

Will Oisín Biotechnologies IPO soon?

No public IPO plans have been announced for Oisín Biotechnologies.

How can I track Oisín Biotechnologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oisín Biotechnologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range13
Year Founded2014
Last FundingDec 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?